Cargando…
Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study
BACKGROUND: Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged ≥85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study—a prospective cohort of people born in 1921 who turned 85 in 2006 (n = 845). METHODS:...
Autores principales: | Davies, Laurie E., Kingston, Andrew, Todd, Adam, Hanratty, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815158/ https://www.ncbi.nlm.nih.gov/pubmed/33465141 http://dx.doi.org/10.1371/journal.pone.0245648 |
Ejemplares similares
-
CHARACTERISING POLYPHARMACY IN THE VERY OLD: FINDINGS FROM THE NEWCASTLE 85+ STUDY
por: Davies, Laurie, et al.
Publicado: (2019) -
Is polypharmacy associated with mortality in the very old: Findings from the Newcastle 85+ Study
por: Davies, Laurie E., et al.
Publicado: (2022) -
Does polypharmacy shape dependency transitions in the very old? Findings from the Newcastle 85+ Study
por: Davies, Laurie E, et al.
Publicado: (2022) -
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study
por: Davies, Laurie E., et al.
Publicado: (2022) -
Publisher Correction to: Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study
por: Davies, Laurie E., et al.
Publicado: (2022)